Gradient Capital Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
1,379
+43
| +3% | +$7.99K | 0.08% | 141 |
|
|
2025
Q1 | $280K | Buy |
1,336
+10
| +0.8% | +$2.1K | 0.09% | 131 |
|
|
2024
Q4 | $236K | Buy |
1,326
+1
| +0.1% | +$178 | 0.08% | 143 |
|
|
2024
Q3 | $262K | Buy |
1,325
+2
| +0.2% | +$395 | 0.09% | 133 |
|
|
2024
Q2 | $227K | Buy |
1,323
+1
| +0.1% | +$172 | 0.08% | 134 |
|
|
2024
Q1 | $241K | Buy |
1,322
+29
| +2% | +$5.28K | 0.09% | 129 |
|
|
2023
Q4 | $200K | Buy |
+1,293
| New | +$200K | 0.08% | 140 |
|